Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308795839> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W4308795839 endingPage "e184" @default.
- W4308795839 startingPage "e182" @default.
- W4308795839 abstract "Despite an expected increase in prostate cancer (PCa) incidence in the renal transplant recipient (RTR) population in the near future, robot-assisted radical prostatectomy (RARP) in these patients has been poorly detailed. It is not well understood whether results are comparable to RARP in the non-RTR setting.To describe the surgical technique for RARP in RTR and report results from our multi-institutional experience.This was a retrospective review of the experience of four referral centers.Transperitoneal RARP with pelvic lymph node dissection in selected patients.We measured patient, PCa, and graft baseline features; intraoperative and postoperative parameters; complications, (Clavien classification); and oncological and functional outcomes.We included 41 men. The median age, American Society of Anesthesiologists score, preoperative renal function, and prostate-specific antigen were 60 yr (interquartile range [IQR] 57–64), 2 points (IQR 2–3), 45 ml/min (IQR 30–62), and 6.5 ng/ml (IQR 5.2–10.2), respectively. Four men (9.8%) had a biopsy Gleason score >7. The majority of the patients (70.7%) did not undergo lymphadenectomy. The median operating time, hospital stay, and catheterization time were 201 min (IQR 170–250), 4 d (IQR 2–6), and 10 d (IQR 7–13), respectively. At final pathology, 11 men had extraprostatic extension and seven had positive surgical margins. At median follow-up of 42 mo (IQR 24–65), four men had biochemical recurrence, including one case of local PCa persistence and one local recurrence. No metastases were recorded while two patients died from non–PCa-related causes. Continence was preserved in 86.1% (p not applicable) and erections in 64.7% (p = 0.0633) of those who were continent/potent before the procedure. Renal function remained unchanged (p = 0.08). No intraoperative complications and one major (Clavien 3a) complication were recorded.RARP in RTR is safe and feasible. Overall, operative, oncological, and functional outcomes are comparable to those described for the non-RTR setting, with graft injury remaining undescribed. Further research is needed to confirm our findings.Robot-assisted removal of the prostate is safe and feasible in patients who have a kidney transplant. Cancer control, urinary and sexual function results, and surgical complications seem to be similar to those for patients without a transplant, but further research is needed." @default.
- W4308795839 created "2022-11-15" @default.
- W4308795839 date "2022-12-01" @default.
- W4308795839 modified "2023-09-25" @default.
- W4308795839 title "Acknowledgement to Reviewers" @default.
- W4308795839 doi "https://doi.org/10.1016/j.eururo.2022.10.016" @default.
- W4308795839 hasPublicationYear "2022" @default.
- W4308795839 type Work @default.
- W4308795839 citedByCount "0" @default.
- W4308795839 crossrefType "journal-article" @default.
- W4308795839 hasConcept C119060515 @default.
- W4308795839 hasConcept C121608353 @default.
- W4308795839 hasConcept C126322002 @default.
- W4308795839 hasConcept C126894567 @default.
- W4308795839 hasConcept C141071460 @default.
- W4308795839 hasConcept C167135981 @default.
- W4308795839 hasConcept C2775862295 @default.
- W4308795839 hasConcept C2777008409 @default.
- W4308795839 hasConcept C2779466945 @default.
- W4308795839 hasConcept C2780192828 @default.
- W4308795839 hasConcept C2780824555 @default.
- W4308795839 hasConcept C2780849966 @default.
- W4308795839 hasConcept C2781406297 @default.
- W4308795839 hasConcept C2908647359 @default.
- W4308795839 hasConcept C71924100 @default.
- W4308795839 hasConcept C99454951 @default.
- W4308795839 hasConceptScore W4308795839C119060515 @default.
- W4308795839 hasConceptScore W4308795839C121608353 @default.
- W4308795839 hasConceptScore W4308795839C126322002 @default.
- W4308795839 hasConceptScore W4308795839C126894567 @default.
- W4308795839 hasConceptScore W4308795839C141071460 @default.
- W4308795839 hasConceptScore W4308795839C167135981 @default.
- W4308795839 hasConceptScore W4308795839C2775862295 @default.
- W4308795839 hasConceptScore W4308795839C2777008409 @default.
- W4308795839 hasConceptScore W4308795839C2779466945 @default.
- W4308795839 hasConceptScore W4308795839C2780192828 @default.
- W4308795839 hasConceptScore W4308795839C2780824555 @default.
- W4308795839 hasConceptScore W4308795839C2780849966 @default.
- W4308795839 hasConceptScore W4308795839C2781406297 @default.
- W4308795839 hasConceptScore W4308795839C2908647359 @default.
- W4308795839 hasConceptScore W4308795839C71924100 @default.
- W4308795839 hasConceptScore W4308795839C99454951 @default.
- W4308795839 hasIssue "6" @default.
- W4308795839 hasLocation W43087958391 @default.
- W4308795839 hasOpenAccess W4308795839 @default.
- W4308795839 hasPrimaryLocation W43087958391 @default.
- W4308795839 hasRelatedWork W1965560101 @default.
- W4308795839 hasRelatedWork W1979955543 @default.
- W4308795839 hasRelatedWork W1981497922 @default.
- W4308795839 hasRelatedWork W2012143060 @default.
- W4308795839 hasRelatedWork W2012250131 @default.
- W4308795839 hasRelatedWork W2116884624 @default.
- W4308795839 hasRelatedWork W2169120358 @default.
- W4308795839 hasRelatedWork W2559494340 @default.
- W4308795839 hasRelatedWork W3150909901 @default.
- W4308795839 hasRelatedWork W3158105150 @default.
- W4308795839 hasVolume "82" @default.
- W4308795839 isParatext "false" @default.
- W4308795839 isRetracted "false" @default.
- W4308795839 workType "article" @default.